Secondary Sclerosis Cholangitis Prospective

计划入组 380 人 · 首次发布于 2018 年 6 月 25 日

Primary Sclerosing Cholangitis in Children

计划入组 1,000 人 · 首次发布于 2019 年 11 月 29 日

Patients With Primary Biliary Cholangitis

计划入组 2,000 人 · 首次发布于 2026 年 5 月 7 日

Primary sclerosing cholangitis(Engitix )

NOX inhibitors (primary biliary cholangitis/head and neck cancer)

Obeticholic acid(Ocaliva)

C₂₆H₄₄O₄ · Rx

Gilead's Seladelpar Receives European Commission Approval for Primary Biliary Cholangitis

New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis

UK Approves Gilead's Livdelzi (Seladelpar) for Primary Biliary Cholangitis